The NCRI Head and Neck Group’s “Bench to bedside HNC research” Working Group sets out to achieve Priority 1 of the NCRI Head and Neck Group Strategic Priorities: To identify the optimal approach for collaboration between basic scientists, translational scientists, and clinicians to engage and collaborate in future head and neck cancer clinical trials.

By addressing this priority, this working group aims to develop a workshop and produce a position paper, with HPV as a possible topic, to encourage collaboration between clinicians and scientists to strengthen clinical trials and ultimately convert discovery science into patient benefit.

You can see the full list of strategic priorities for the NCRI Head and Neck Group here.